LifeStance Health Group (NASDAQ:LFST) PT Lowered to $6.00 at Barclays

LifeStance Health Group (NASDAQ:LFST) had its target price trimmed by Barclays from $8.00 to $6.00 in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has an underweight rating on the stock.

Separately, Morgan Stanley reissued an overweight rating and set a $10.00 price target on shares of LifeStance Health Group in a research note on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Hold and an average price target of $8.40.

LifeStance Health Group Price Performance

LFST stock traded down $0.07 on Friday, reaching $5.53. The company had a trading volume of 11,625 shares, compared to its average volume of 1,512,550. LifeStance Health Group has a 1 year low of $4.64 and a 1 year high of $9.20. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18. The company’s fifty day moving average is $5.38 and its 200 day moving average is $6.08. The company has a market cap of $2.11 billion, a P/E ratio of -11.67 and a beta of 1.20.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The firm had revenue of $312.30 million for the quarter, compared to analyst estimates of $305.85 million. During the same quarter in the prior year, the company earned ($0.13) EPS. LifeStance Health Group’s revenue was up 20.3% on a year-over-year basis. On average, research analysts forecast that LifeStance Health Group will post -0.25 earnings per share for the current year.

Insider Activity at LifeStance Health Group

In related news, insider Danish J. Qureshi sold 150,000 shares of the stock in a transaction on Friday, June 14th. The stock was sold at an average price of $5.21, for a total value of $781,500.00. Following the completion of the sale, the insider now directly owns 439,002 shares in the company, valued at approximately $2,287,200.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Danish J. Qureshi sold 150,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The stock was sold at an average price of $5.21, for a total transaction of $781,500.00. Following the completion of the sale, the insider now directly owns 439,002 shares in the company, valued at $2,287,200.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the firm’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total value of $22,395,812.05. Following the sale, the insider now owns 41,932,358 shares of the company’s stock, valued at $246,981,588.62. The disclosure for this sale can be found here. In the last three months, insiders sold 4,037,438 shares of company stock worth $23,647,876. Corporate insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Large investors have recently modified their holdings of the business. Bessemer Group Inc. lifted its position in shares of LifeStance Health Group by 43.4% during the first quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock worth $56,000 after purchasing an additional 2,768 shares during the last quarter. CIBC Asset Management Inc bought a new position in shares of LifeStance Health Group during the second quarter worth about $53,000. Assetmark Inc. lifted its position in shares of LifeStance Health Group by 21.6% during the fourth quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock worth $93,000 after purchasing an additional 2,114 shares during the last quarter. Stratos Wealth Partners LTD. bought a new position in shares of LifeStance Health Group during the fourth quarter worth about $93,000. Finally, Allen Investment Management LLC bought a new position in shares of LifeStance Health Group during the first quarter worth about $79,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.